The rod photoreceptor phosphodiesterase (PDE) is unique among all known vertebrate PDE families for several reasons: it is a catalytic heterodimer (αβ), it is directly activated by a Gprotein, transducin, and its active sites are regulated by inhibitory γ subunits. Rod PDE binds cGMP at two noncatalytic sites on the αβ dimer but their function is unclear. We show that transducin activation of frog rod PDE introduces functional heterogeneity to both the noncatalytic and catalytic sites. Upon PDE activation, one noncatalytic site is converted from a high affinity to low affinity state, while the second binding site undergoes modest decreases in binding. Addition of γ to transducin-activated PDE can restore high affinity binding as well as reducing cGMP exchange kinetics at both sites. A strong correlation exists between cGMP binding and γ binding to activated PDE: dissociation of bound cGMP accompanies γ dissociation from PDE, while addition of either cGMP or γ to αβ dimers can restore high affinity binding of the other molecule. At the active site, transducin can activate PDE to about one-half the turnover number for catalytic αβ dimers completely lacking bound γ subunit. These results suggest a mechanism in which transducin interacts primarily with one PDE catalytic subunit, releasing its full catalytic activity as well as inducing rapid cGMP dissociation from one noncatalytic site.
Summary
The rod photoreceptor phosphodiesterase (PDE) is unique among all known vertebrate PDE families for several reasons: it is a catalytic heterodimer (αβ), it is directly activated by a Gprotein, transducin, and its active sites are regulated by inhibitory γ subunits. Rod PDE binds cGMP at two noncatalytic sites on the αβ dimer but their function is unclear. We show that transducin activation of frog rod PDE introduces functional heterogeneity to both the noncatalytic and catalytic sites. Upon PDE activation, one noncatalytic site is converted from a high affinity to low affinity state, while the second binding site undergoes modest decreases in binding. Addition of γ to transducin-activated PDE can restore high affinity binding as well as reducing cGMP exchange kinetics at both sites. A strong correlation exists between cGMP binding and γ binding to activated PDE: dissociation of bound cGMP accompanies γ dissociation from PDE, while addition of either cGMP or γ to αβ dimers can restore high affinity binding of the other molecule. At the active site, transducin can activate PDE to about one-half the turnover number for catalytic αβ dimers completely lacking bound γ subunit. These results suggest a mechanism in which transducin interacts primarily with one PDE catalytic subunit, releasing its full catalytic activity as well as inducing rapid cGMP dissociation from one noncatalytic site.
INTRODUCTION
Initiation of the phototransduction cascade in vertebrate rod photoreceptors by light results in the sequential activation of the visual pigment (rhodopsin), the photoreceptor G-protein (transducin), and the effector enzyme (cGMP phosphodiesterase, PDE 1 )[for reviews, see ref. (1) (2) (3) (4) ]. The PDE present in rod and cone photoreceptors (classified as PDE6) differs in several ways from other classes of mammalian phosphodiesterases (5-7): rod photoreceptor PDE forms a catalytic dimer from two closely related α and β subunits (Pαβ); rod and cone PDE are directly regulated via heterotrimeric G-proteins; the catalytic constant (k cat ) for rod PDE is ~1000-fold greater than for any other class of PDE; the catalytic activity of photoreceptor PDE is potently inhibited by binding of an inhibitory γ subunit (Pγ) [for reviews, see ref. (8, 9) ].
Transducin activation of PDE results from binding of the activated transducin α t subunit (α t -GTP) to one or more sites on the PDE holoenzyme. One result of this interaction is the displacement of the inhibitory Pγ subunit from its binding site in the catalytic pocket of PDE. It is not clear, however, whether each PDE catalytic subunit binds Pγ with equal affinity, whether α t -GTP can activate each catalytic site equally well, and under what conditions the α t -GTP-Pγ complex dissociates from Pαβ. Conflicting results reported by different laboratories may reflect 4 For PDE5, the noncatalytic sites allosterically regulate accessibility of a phosphorylation site that alters catalytic activity (32-34). The possible regulatory function for the low affinity, noncatalytic sites on PDE10 is not known, nor is it known whether the GAF domains in PDE 11 represent functional cGMP binding sites.
Since the initial findings by Yamazaki et al. (35, 36 ) that cGMP bound with high affinity to rod photoreceptor PDE, several possible roles for the noncatalytic sites on rod PDE have been proposed. One hypothesis is that cGMP occupancy of the noncatalytic sites on PDE affects the strength of the interaction between the inhibitory Pγ subunit and Pαβ [reviewed in ref. (9)]. It has also been proposed that changes in cGMP binding affinity to the noncatalytic sites during visual transduction might permit the release of bound cGMP to accelerate the restoration of cGMP levels during the recovery phase of the photoresponse (37, 38) . Finally, the idea that the noncatalytic sites on photoreceptor PDE might directly regulate hydrolysis of cGMP at the active site (as is the case for PDE2) has not been supported by current evidence (22, 39) .
In this paper, we characterize the properties of non-activated, transducin-activated, and catalytic dimers of PDE, all derived from suspensions of purified amphibian rod outer segments, in order to provide a detailed account of the changes that occur at the catalytic and noncatalytic domains of PDE upon light activation of the phototransduction cascade. We demonstrate a direct correlation between occupancy of cGMP at the noncatalytic sites of PDE and the state of association of the inhibitory Pγ subunit. Our results are consistent with transducin activation 7 We verified that the integral membrane protein, rhodopsin, was present in the supernatant at undetectable levels and that >95% of the total rhodopsin could be recovered in the membrane pellet under these conditions. Recombinant bovine rod Pγ was expressed in E. coli and purified to >97% purity as described in ref. (42) . The Pγ concentration was determined spectrophotometrically using an experimentally determined extinction coefficient of 7550 OD M -1 (40) . The inhibitory activity of purified Pγ was assayed by its ability to stoichiometrically inhibit trypsin-activated bovine rod PDE (43); the spectrophotometric and activity estimates of Pγ concentration agreed to within 10% for all Pγ preparations used in this study.
PDE preparations used in this study. Since PDE6 is the only detectible isoform of phosphodiesterase in purified ROS, no additional purification of the rod PDE was required. Nonactivated PDE (nPDE) was obtained directly from nucleotide-depleted ROS homogenates; in the absence of GTP, dark-adapted and light-exposed ROS homogenates show no difference in the rate of cGMP hydrolysis or in the extent of cGMP binding. The catalytic activity of nPDE was typically 1-3% of the activated rate at the concentrations used in this paper (D'Amours and Cote, 8 exposure of PDE to the protease yielding full activation (see Results). Excessive proteolysis of PDE leads to a gradual loss in the maximal catalytic activity, as well as irreversible damage to the noncatalytic sites. We prepared PDE heterodimers (Pαβ) depleted of Pγ by modifying the original method of Yamazaki et al. (15) : nPDE was incubated with GTPγS for 60 min at 4º to allow Pγ to dissociate from Pαβ, and then centrifuged in the Airfuge to pellet ROS membranes.
The supernatant was discarded and the ROS membrane treated with GTPγS once more to further release membrane-bound Pγ. Following the second centrifugation, ROS membranes retained all of the original Pαβ content, but only 10-35% of the original Pγ (depending on the individual preparation). [The content of α t in GTPγS-washed ROS membranes was also reduced to <30% of its concentration in ROS homogenates, as judged by immunoblot analysis with anti-α t antibodies.] Pαβ was used immediately following its preparation, because the enzyme was unstable once most of the Pγ had been removed. Only preparations containing <25% of the original Pγ content (i.e., < 0.5 Pγ per PDE) were used in experiments employing Pαβ. Efforts to completely eliminate Pγ from our Pαβ preparations were unsuccessful.
Binding of cGMP to noncatalytic sites on PDE. Because PDE is the only rod photoreceptor protein that binds cGMP with high affinity (K D < µM) (37,44), we were able to measure changes in binding occupancy at the noncatalytic sites of PDE in unfractionated ROS homogenates. For most experiments, a cGMP filter binding assay (40) 
Quantitative immunoblot analysis of Pγ concentration in ROS. Samples for Pγ analysis
were added to electrophoresis sample buffer, and then subjected to sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). After electrophoretic transfer to a 0.45 µm nitrocellulose membrane, the presence of Pγ was detected with an affinity-purified rabbit polyclonal antibody (UNH9710-4P; 1:15,000 dilution) specific for amino acid residues 63-87 of bovine rod Pγ. [Frog (Rana pipiens) Pγ has an identical amino acid sequence to bovine Pγ in this region; Wolfgang Baehr, personal communication.] Binding of the Pγ antibody was determined using a goat anti-rabbit antibody coupled to horseradish peroxidase (1:4000 dilution), followed by incubation of the membrane with substrate (SuperSignal West Pico Chemiluminescent Substrate, Pierce) and luminescent detection on film (Kodak BioMax Light). The intensity of the Pγ immunoreactive bands was recorded using a scanner and analyzed using the image analysis program, Quantiscan (Biosoft). The concentration of Pγ in ROS samples was calculated by comparison to a standard curve generated with known amounts (0.5 -15 ng) of recombinant Pγ on the same blot, as described in detail elsewhere (40) .
PDE activity assay. The rate of cGMP hydrolysis catalyzed by non-activated and activated forms of PDE was measured by a coupled-enzyme phosphate release assay, as described in detail in ref. (40) . Activity measurements were made in the following buffer: 100 mM Tris, 10 mM MgCl 2 , 0.5 mM EDTA, 2 mM dithiothreitol, 0.5 mg/ml bovine serum albumin, pH 7.5. In all cases, rate measurements were obtained from at least three individual time points at saturating cGMP concentrations (10 mM), during which time less than 30% of the substrate was consumed.
Other methods. SDS-PAGE was performed by the method of Laemmli in 15% acrylamide gels (47). The immunoblotting protocol closely followed standard procedures (48) .
Fitting of PDE activity data was carried out with nonlinear regression analysis using Sigmaplot.
Equilibrium binding data as well as the kinetics of cGMP association and dissociation were analyzed as described in ref. (40) ; in all cases, statistical comparisons of one-site versus two-site fits were carried out using KELL (Biosoft) to determine whether PDE exhibited one or two distinct classes of cGMP binding sites.
RESULTS AND DISCUSSION
Transducin activation of PDE converts one class of noncatalytic sites to a low affinity, rapidly exchanging state. While it has been reported that transducin activation of photoreceptor PDE leads to changes in cGMP binding to the noncatalytic sites of the enzyme, the regulatory and physiological significance of this process is not well understood. A previous study reported Table 1 ). The measured K D for cGMP binding to frog nPDE agrees with previous estimates when the temperature dependence of the binding reaction is accounted for (37) . [The B max of nPDE can be increased to 2.0 by addition of ≤ 1 Pγ per PDE (see Fig. 2C ), suggesting that a small amount of Pγ was lost during preparation of nPDE.] When transducin is activated by addition of GTPγS to illuminated ROS homogenates and then 10 -400 nM [ = 1.0 mol cGMP per mol PDE; Table 1 ). At higher [ (Fig. 1A) , and the association rate constant is identical for nPDE and taPDE (Table 1) 
Exogenous Pγ regulates cGMP exchange rates at both low and high affinity noncatalytic sites on PDE.
To test the role of Pγ to regulate cGMP binding to the noncatalytic sites on nPDE and taPDE, we examined whether adding Pγ affected cGMP dissociation from nPDE and taPDE. Fig. 2A shows that when nPDE is incubated with increasing amounts of Pγ and then 1 µM Pre-incubation of taPDE with increasing amounts of Pγ prior to transducin activation has two major effects on the noncatalytic cGMP binding sites. First, Pγ can convert low affinity cGMP binding sites on taPDE to high affinity sites (Fig. 2C) . Second, addition of increasing amounts of Pγ can reduce (1 Pγ added per taPDE) or abolish (≥ 2 Pγ added per taPDE) the rapidly dissociating class of noncatalytic sites on taPDE, as well as slowing cGMP dissociation from the other class of sites to a similar extent as nPDE (Fig. 2B ). It is noteworthy that Pγ exerts these effects on the noncatalytic cGMP binding sites with greater potency than it can inhibit catalysis at the active site of taPDE (see Fig. 7 ).
Quantitative analysis of the Pγ concentration and its subcellular location in purified frog
ROS. Because free Pγ greatly affects cGMP binding and exchange kinetics with PDE, we decided to measure the Pγ concentration in intact frog ROS as well as the stoichiometry of Pγ binding to frog Pαβ. Using a quantitative immunoblot procedure, we found that homogenates derived from Percoll-purified frog ROS contained 1.81 ± 0.13 (mean ± S.E.M.; n = 14) mol of Pγ relative to the total concentration of PDE holoenzyme (Fig. 3, "Homog." ). Upon fractionation of these ROS homogenates into membrane and soluble fractions by centrifugation, both darkadapted and light-exposed ROS retain all Pγ (1.9 -2.0 Pγ per Pαβ) in a membrane-associated state, and < 0.1 Pγ per Pαβ in the soluble fractions (Fig. 3, "Control") . The membrane-associated Pγ was bound to PDE, because when frog PDE was released from ROS membranes by hypotonic extraction, a similar stoichiometry of Pγ binding to the released PDE was observed (data not shown).
Addition of cGMP to saturate the noncatalytic sites on PDE did not alter the membrane- We conclude that the frog rod PDE holoenzyme consists of a Pαβ catalytic dimer to which 2 Pγ subunits bind, identical to the αβγ 2 stoichiometry of membrane-associated bovine rod PDE holoenzyme (52, 53) (Fig. 4) . Both processes showed biphasic dissociation kinetics, with 20-30% of the reaction occurring rapidly (t 1/2 = 0.6 -0.7 min), and the remainder of the dissociation reaction occurring much more slowly (t 1/2 = 40-60 min).
Experimental limitations prevented us from determining the temporal sequence of Pγ and cGMP dissociation from Pαβ. However, it is likely that interaction of α t -GTPγS with Pγ bound to the PDE holoenzyme initially displaces Pγ from its tight association with one catalytic subunit, thereby accelerating cGMP dissociation from the noncatalytic site. Loss of cGMP at this noncatalytic site would further lower the Pγ binding affinity for Pαβ, leading to dissociation of Pγ-α t -GTPγS from Pαβ. The observation that cGMP and Pγ dissociation from the other class of binding sites proceeds as slowly as for nPDE (Fig. 1B) indicates that α t -GTPγS is much less effective in binding to the second Pγ molecule and accelerating cGMP exchange at this noncatalytic site. This might be explained if the remaining Pγ bound with higher intrinsic affinity to Pαβ than the Pγ that is rapidly released.
cGMP occupancy of the noncatalytic sites induces stoichiometric binding of Pγ to taPDE.
We next asked whether occupancy of the noncatalytic cGMP binding sites on taPDE was sufficient to reverse Pγ dissociation from Pαβ. We first prepared taPDE lacking bound cGMP, and then added increasing concentrations of [ (Fig. 3, " +cGMP & GTPγS").
We conclude that cGMP occupancy of the noncatalytic sites must induce a conformational change in the Pαβ catalytic dimer that enhances Pγ binding to Pαβ. This allosteric effect of cGMP to enhance Pγ binding affinity does not act on the C-terminal inhibitory domain of Pγ (55), because taPDE remains catalytically activated (see Table 2 ). Rather, a distinct domain on Pγ [e.g., the central polycationic domain; (56)] must be involved in interacting with Pαβ in a cGMP-dependent manner. Fig. 2C, Fig. 5 ). Addition of ≥ 4 Pγ per Pαβ fully restores cGMP binding to a second class of sites that were unoccupied at lower Pγ concentrations (consistent with the results in Fig. 2C for taPDE) . The results shown in Fig. 6 were also observed when Pαβ was prepared by activating transducin with GTP instead of GTPγS (data not shown). The data in Transducin activation fails to stimulate the maximum catalytic potential of the Pαβ catalytic heterodimer. Based on the above results, we hypothesized that heterogeneity in Pγ binding to Pαβ might also result in differences in catalysis at the two active sites on Pαβ. While most previous work has assumed that each catalytic subunit contributes equally to catalysis upon activation of PDE by transducin, there is wide variation in the reported maximal hydrolytic rates for activated PDE [see Table V in (2)] as well as uncertainty in the stoichiometry and cooperativity of transducin activation of PDE [see (24) and references cited therein].
Two distinct classes of Pγ binding sites on
We compared the rates of cGMP hydrolysis for various forms of activated PDE that differed in the method by which the inhibitory constraint of Pγ was relieved. To determine the maximum hydrolytic rate of taPDE, we measured the enzyme activity in light-exposed ROS homogenates following addition of increasing concentrations of GTPγS. Complete activation of PDE by transducin required a concentration of GTPγS sufficient to activate the entire pool of transducin in ROS (data not shown). The k cat for taPDE, 4560 ± 140 cGMP per s (Table 2) is not significantly different from a previous estimate of 4400 cGMP per s (21).
We used the same frog ROS homogenates to directly compare taPDE with PDE activated by trypsin proteolysis (tPDE). We found that the k cat in the latter case was substantially higher, in contrast to previous comparisons using frog PDE (14, 58) . In one set of experiments where we added increasing concentrations of trypsin to 2 nM PDE, we found a maximum catalytic rate of 7640 ± 140 cGMP hydrolyzed per s (n = 5; data not shown). In additional experiments where hydrolytic activity measurements were made at relatively low tPDE concentrations (0.5 to 3 nM PDE), we observed similarly high rates (Table 2) . If hydrolytic activity of tPDE was assayed at substantially higher enzyme concentrations (15 -30 nM tPDE), the maximal rate approached the k cat for taPDE (Table 2 ). In a separate experiment, progressive dilution of tPDE from 3 nM to 0.5 nM caused the hydrolytic activity to increase from 6400 to 8100 cGMP per s per PDE; further dilution to 6 pM tPDE had no further effect on the apparent k cat . We attribute this phenomenon to the presence of proteolytic fragments of Pγ in our tPDE preparations that retain the ability to bind to and inhibit Pαβ at high, but not low, PDE concentrations. A 4.6 kDa Pγ-immunoreactive band [corresponding to amino acids 46 to 87 of bovine Pγ (56)] has been detected on immunoblots of tPDE preparations, and co-purifies with tPDE following gel filtration chromatography (data not shown).
We have also measured the maximal cGMP hydrolytic rates of Pαβ preparations in which 75 -85% of the endogenous Pγ has been extracted by α t -GTPγS. We find catalytic rates substantially greater (range, 5000 -6600 cGMP per s) than the k cat for taPDE. When corrected for the residual Pγ content of these Pαβ preparations, the predicted k cat of Pαβ dimer devoid of Pγ is 7000 ± 180 cGMP per sec (n = 8; Table 2 ). Trypsinization of these Pαβ preparations containing residual Pγ can further elevate the hydrolytic rate approximately 25%.
We conclude that the maximum catalytic potential of the Pαβ catalytic dimer approaches 8000 cGMP hydrolyzed per s per Pαβ when all Pγ is released from the enzyme. If we assume each catalytic subunit has the same turnover number (4000 cGMP per s per subunit) and the K M for tPDE is 22 µM (22), the specificity constant, k cat /K M is calculated to be 1. Thus, the catalysis of cGMP into 5'-GMP occurs with extremely high catalytic efficiency and very near the diffusion limit (49) . However, PDE never achieves this level of activation in vivo, because transducin activation of the enzyme fails to fully relieve Pγ inhibition at both active sites. Rather, α t -GTPγS acts to completely relieve inhibition at only one of the two active sites on Pαβ, with perhaps a minor (≤ 10%) effect at the second catalytic site. Activation of PDE catalysis by one, not two, activated transducin molecules in frog ROS homogenates is consistent with the 1:1 stoichiometry of bovine rod PDE activation by transducin in a purified, reconstituted system (24) .
Exogenous Pγ can stoichiometrically inhibit Pαβ catalytic dimers, but not taPDE.
To further probe how transducin binds to and activates the PDE holoenzyme, we examined the ability of exogenous Pγ to inhibit the various forms of activated PDE used in this paper. Previous studies using tPDE or Pαβ preparations offer conflicting views on the ability of Pγ to inhibit activated frog PDE. In some reports, activated PDE can be inhibited by Pγ as a single class of high affinity sites (38, 57) , exhibiting the same titration behavior observed with bovine tPDE [e.g., refs. (11, 43, 59) ]. Other studies with activated frog PDE show evidence for lower affinity Pγ binding and/or complex inhibition of catalysis by added Pγ (14, 15, 36) . These differing results may arise from a number of factors, including the concentration of PDE catalytic subunits used, residual Pγ in the activated PDE preparations, and uncertainties in determining the active Pαβ and/or Pγ concentrations.
To resolve these discrepancies, we examined the ability of Pγ to inhibit activated PDE under conditions where the catalytic and inhibitory subunit concentrations were precisely determined. affinity of Pγ for frog PDE reported previously (22) . The similar behavior for tPDE and Pαβ in Fig. 7 shows that trypsinization of PDE acts primarily on Pγ and has no noticeable effect on the ability of Pαβ subunits to be inhibited by added Pγ. Although α t -GTPγS is present in our Pαβ preparations (see "Experimental Procedures") and is capable of binding free Pγ (15) , the stoichiometric inhibition of Pαβ by Pγ demonstrates that α t -GTPγS cannot compete effectively with Pαβ for binding to Pγ under these conditions. Thus, in both instances where activated PDE has had its Pγ physically removed from the catalytic dimer, exogenous Pγ has free access to and high affinity for the catalytic sites and can stoichiometrically inhibit catalysis.
In contrast, the inhibition of taPDE by addition of Pγ requires a greater than 15-fold molar excess of Pγ to fully inhibit catalytic activity (Fig. 7) . The potency of Pγ inhibition at the active site is several-fold weaker than its ability to convert low affinity noncatalytic binding sites on taPDE to higher affinity sites (Fig. 2C) . Note that in the presence of millimolar levels of cGMP in Fig. 7 , taPDE binds 2 mol endogenous Pγ per mol PDE (Fig. 3) , and has a catalytic activity about one-half of the maximal rate of Pαβ (Table 2) . It is likely, therefore, that taPDE exists as a complex of α t -GTPγS with the PDE holoenzyme. We speculate that a molecule of α t -GTPγS, in a complex with Pγ and a catalytic subunit, hinders the free diffusion of exogenous Pγ to its inhibitory binding site, thereby reducing the effectiveness of free Pγ to inhibit cGMP hydrolysis compared to tPDE or Pαβ preparations.
Role of the noncatalytic cGMP binding sites during transducin activation of PDE.
Our results suggest that the noncatalytic sites on photoreceptor PDE detect changes in cytoplasmic cGMP concentration during phototransduction, and allosterically regulate the state of association of Pγ with PDE and with activated transducin. In the dark-adapted state, cGMP levels in rod photoreceptors are much higher (> 1 µM) than the K D for cGMP binding to the noncatalytic sites of nPDE. Consequently, Pγ remains bound to both catalytic subunits in its inhibitory conformation, and cGMP and Pγ exchange between the bound and free states is expected to be very slow (Fig. 8, "nPDE") .
Transient light activation of the visual excitation pathway causes activated α t to displace Pγ from its inhibitory conformation, and cGMP rapidly drops below micromolar levels.
However, the recovery of the dark-adapted state in response to dim flashes (time scale, seconds) probably restores cGMP levels (via guanylate cyclase activation) more rapidly than cGMP can dissociate from noncatalytic sites. Under these conditions, activated PDE would consist of a complex of PDE holoenzyme (both noncatalytic sites occupied, both Pγ bound to Pαβ, and one catalytic site fully active; Fig. 8 , "taPDE-A") and activated α t . PDE inactivation would depend upon the intrinsic GTPase rate of transducin converting activated α t -GTP to inactive α t -GDP.
Persistent activation of the phototransduction cascade by continuous illumination or bright flashes of light causes cytoplasmic cGMP levels to remain below the K D for the low affinity sites on taPDE long enough for cGMP to dissociate from the low affinity noncatalytic sites. Pγ dissociation will occur at the same rate because of the highly cooperative nature of Pγ and cGMP binding to PDE (Fig. 8, "taPDE-B") . The Pγ that is released is known to serve as a GTPase-accelerating factor for α t -GTP-in combination with the Regulator of G-protein Signaling-9 (RGS-9) and the G-protein β 5L subunit (60) (61) (62) . This would speed up transducin inactivation, diminish the amplitude of the light response, and act as a feedback regulator for light adaptation.
relatively unaffected by activation of the rod phototransduction cascade, in terms of catalytic activation, Pγ release, or cGMP dissociation (Fig. 8, right-hand subunit) . Only under certain in vitro conditions does this subunit undergo changes in ligand binding or catalytic activity. A higher intrinsic affinity of this catalytic subunit for Pγ may account for this phenomenon.
Additional experiments are needed to test the hypothesis that the noncatalytic sites on PDE serve as a detector of the cGMP concentration in rod photoreceptors during light adaptation. Future work will focus on better understanding the properties of the low affinity noncatalytic sites on activated PDE, identifying the structural basis for catalytic subunit heterogeneity, and examining whether the homodimeric cone PDE employs similar regulatory mechanisms in cone photoreceptors. The concentration of PDE used to assay the hydrolytic rate. The maximal rate was calculated by correcting the observed rate in each experiment for the residual Pγ (15 -25%) remaining bound to Pαβ, assuming a linear dependence of the observed rate with the Pγ content (see Fig. 7 ).
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